The University of Chicago Header Logo

Connection

J. Thistlethwaite to Graft Survival

This is a "connection" page, showing publications J. Thistlethwaite has written about Graft Survival.
Connection Strength

2.005
  1. Absence of host B7 expression is sufficient for long-term murine vascularized heart allograft survival. Transplantation. 2000 Mar 15; 69(5):904-9.
    View in: PubMed
    Score: 0.140
  2. Synchronous pancreas-kidney transplantation with portal venous and enteric exocrine drainage: outcome in 70 consecutive cases. Transplant Proc. 1998 Mar; 30(2):270-1.
    View in: PubMed
    Score: 0.122
  3. Retransplantation for failed hepatic allografts in children. Transplant Proc. 1997 Feb-Mar; 29(1-2):442-3.
    View in: PubMed
    Score: 0.113
  4. Impact of a liberalized donor acceptance policy on liver transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):484.
    View in: PubMed
    Score: 0.113
  5. Kidney Donor Profile Index Does Not Accurately Predict the Graft Survival of Pediatric Deceased Donor Kidneys. Transplantation. 2016 Nov; 100(11):2471-2478.
    View in: PubMed
    Score: 0.111
  6. Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation. Transplant Proc. 1996 Aug; 28(4):2136-7.
    View in: PubMed
    Score: 0.109
  7. Intrathymic xenogeneic pancreatic islet transplantation--induction of donor-specific unresponsiveness by MHC class II peptides. Transplant Proc. 1995 Feb; 27(1):176-7.
    View in: PubMed
    Score: 0.099
  8. Immunomodulation of human islets results in prolonged in vivo islet graft survival. Transplant Proc. 1995 Feb; 27(1):611-2.
    View in: PubMed
    Score: 0.099
  9. Prolongation of skin xenograft survival with concomitant donor bone marrow transplantation. Transplant Proc. 1994 Jun; 26(3):1201-2.
    View in: PubMed
    Score: 0.094
  10. Low-dose anti-CD3 therapy provides long-term graft survival in a Lewis rat to C57BL/6 xeno-islet transplantation model. Transplant Proc. 1994 Apr; 26(2):771-3.
    View in: PubMed
    Score: 0.093
  11. Living related liver transplantation in children: a report of the first 58 recipients at the University of Chicago. Transpl Int. 1994; 7 Suppl 1:S111-3.
    View in: PubMed
    Score: 0.091
  12. Does depletion of donor dendritic cells in an organ allograft lead to prolongation of graft survival on transplantation? Transplant Proc. 1989 Feb; 21(1 Pt 1):482-3.
    View in: PubMed
    Score: 0.065
  13. Shared decision making in deceased-donor transplantation. Lancet. 2006 Jul 22; 368(9532):333-7.
    View in: PubMed
    Score: 0.055
  14. Reduced acute rejection and superior 1-year renal allograft survival with basiliximab in patients with diabetes mellitus. The Global Simulect Study Group. Transplantation. 2000 Sep 15; 70(5):784-90.
    View in: PubMed
    Score: 0.036
  15. Differential effect of an anti-CD8 monoclonal antibody on rejection of murine intestine and cardiac allografts. Transplant Proc. 1999 Feb-Mar; 31(1-2):1239-41.
    View in: PubMed
    Score: 0.032
  16. Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation. Transplant Proc. 1998 Jun; 30(4):1538-40.
    View in: PubMed
    Score: 0.031
  17. An analysis of hepatic retransplantation in children. Transplantation. 1998 May 15; 65(9):1172-8.
    View in: PubMed
    Score: 0.031
  18. Long-term outcome of kidney-pancreas transplant recipients with good graft function at one year. Transplantation. 1996 Aug 27; 62(4):451-6.
    View in: PubMed
    Score: 0.027
  19. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Clin Transplant. 1996 Aug; 10(4):323-32.
    View in: PubMed
    Score: 0.027
  20. Pancreas transplantation with portal venous drainage and enteric exocrine drainage offers early advantages without compromising safety or allograft function. Transplant Proc. 1995 Dec; 27(6):3002-3.
    View in: PubMed
    Score: 0.026
  21. Late complications in kidney-pancreas transplant recipients. Transplant Proc. 1995 Dec; 27(6):3118.
    View in: PubMed
    Score: 0.026
  22. Disclosing Health and Health Behavior Information between Living Donors and Their Recipients. Clin J Am Soc Nephrol. 2015 Sep 04; 10(9):1609-16.
    View in: PubMed
    Score: 0.026
  23. OKT3 prophylaxis improves long-term renal graft survival in high-risk patients as compared to cyclosporine: combined results from the prospective, randomized Belgian and US studies. Transplant Proc. 1995 Feb; 27(1):852-3.
    View in: PubMed
    Score: 0.025
  24. Decision making in liver transplantation--limited application of the liver donor risk index. Liver Transpl. 2014 Jul; 20(7):831-7.
    View in: PubMed
    Score: 0.024
  25. Prolongation of human pancreatic islet xenografts by pretreatment of islets with anti-human ICAM-1 monoclonal antibody. Transplant Proc. 1994 Jun; 26(3):1120.
    View in: PubMed
    Score: 0.024
  26. A K-nearest neighbors survival probability prediction method. Stat Med. 2013 May 30; 32(12):2062-9.
    View in: PubMed
    Score: 0.022
  27. OKT3 induction in pediatric renal transplantation. Pediatr Nephrol. 1993 Feb; 7(1):45-9.
    View in: PubMed
    Score: 0.021
  28. A randomized clinical trial of induction therapy with OKT3 in kidney transplantation. Transplantation. 1993 Jan; 55(1):44-50.
    View in: PubMed
    Score: 0.021
  29. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science. 1992 Aug 07; 257(5071):789-92.
    View in: PubMed
    Score: 0.021
  30. Pediatric liver transplantation at the University of Chicago Hospitals. Clin Transpl. 1992; 179-89.
    View in: PubMed
    Score: 0.020
  31. [Preservation of donor livers with University of Wisconsin solution]. Helv Chir Acta. 1991 Jul; 58(1-2):159-61.
    View in: PubMed
    Score: 0.019
  32. Risk, prognosis, and unintended consequences in kidney allocation. N Engl J Med. 2011 Apr 07; 364(14):1285-7.
    View in: PubMed
    Score: 0.019
  33. Laser Doppler blood flow measurement as a predictor of viability of renal allografts. Curr Surg. 1990 Nov-Dec; 47(6):431-2.
    View in: PubMed
    Score: 0.018
  34. Aggressive needle biopsy protocol prevents loss of renal allografts to undetected rejection during early posttransplant dysfunction. Transplant Proc. 1989 Feb; 21(1 Pt 2):1890-2.
    View in: PubMed
    Score: 0.016
  35. Improved results of preservation of hepatic grafts preflushed with albumin and prostaglandins. Transplant Proc. 1988 Oct; 20(5):992-3.
    View in: PubMed
    Score: 0.016
  36. Use of a brief steroid trial before initiating OKT3 therapy for renal allograft rejection. Am J Kidney Dis. 1988 Feb; 11(2):94-8.
    View in: PubMed
    Score: 0.015
  37. OKT3 treatment of steroid-resistant renal allograft rejection. Transplantation. 1987 Feb; 43(2):176-84.
    View in: PubMed
    Score: 0.014
  38. Elective conversion from cyclosporine to azathioprine in recipients with stable renal function 6 months after kidney transplantation. Hum Immunol. 1985 Nov; 14(3):314-23.
    View in: PubMed
    Score: 0.013
  39. Effect of class II antigen matching on renal allograft survival in miniature swine. J Exp Med. 1984 Nov 01; 160(5):1495-508.
    View in: PubMed
    Score: 0.012
  40. CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costimulatory pathway. Transplantation. 2001 May 15; 71(9):1351-4.
    View in: PubMed
    Score: 0.010
  41. Different mechanisms of cardiac allograft rejection in wildtype and CD28-deficient mice. Am J Transplant. 2001 May; 1(1):38-46.
    View in: PubMed
    Score: 0.009
  42. Transplantation and the CD28/CTLA4/B7 pathway. Transplant Proc. 2001 Feb-Mar; 33(1-2):209-11.
    View in: PubMed
    Score: 0.009
  43. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance. J Immunol. 2000 Nov 15; 165(10):5580-7.
    View in: PubMed
    Score: 0.009
  44. Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group. Transplantation. 1999 Oct 27; 68(8):1117-24.
    View in: PubMed
    Score: 0.009
  45. Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach. Transplant Proc. 1998 Jun; 30(4):1234-5.
    View in: PubMed
    Score: 0.008
  46. Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation. J Immunol. 1997 Dec 01; 159(11):5187-91.
    View in: PubMed
    Score: 0.007
  47. OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: association with improvement in long-term survival. Kidney Int. 1996 Mar; 49(3):768-72.
    View in: PubMed
    Score: 0.007
  48. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies. Transplantation. 1994 Sep 27; 58(6):681-9.
    View in: PubMed
    Score: 0.006
  49. A non-activating "humanized" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo. Transplantation. 1994 Jun 15; 57(11):1537-43.
    View in: PubMed
    Score: 0.006
  50. Use of cryopreserved vein allogeneic homografts in liver transplantation. Transplant Proc. 1993 Feb; 25(1 Pt 2):1091-2.
    View in: PubMed
    Score: 0.005
  51. Liver transplantation in children from living related donors. Surgical techniques and results. Ann Surg. 1991 Oct; 214(4):428-37; discussion 437-9.
    View in: PubMed
    Score: 0.005
  52. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg. 1990 Sep; 212(3):368-75; discussion 375-7.
    View in: PubMed
    Score: 0.005
  53. Transplantation of two patients with one liver. Analysis of a preliminary experience with 'split-liver' grafting. Ann Surg. 1990 Jul; 212(1):14-22.
    View in: PubMed
    Score: 0.004
  54. Reduced-size orthotopic liver transplantation: use in the management of children with chronic liver disease. Hepatology. 1989 Nov; 10(5):867-72.
    View in: PubMed
    Score: 0.004
  55. Potent immunosuppression overcomes immunologic high-risk factors in recipients of cadaveric renal allografts. Am Surg. 1987 Jul; 53(7):407-9.
    View in: PubMed
    Score: 0.004
  56. An immunosuppressive protocol compatible with the United States kidney transplant diagnosis related grouping. Transplant Proc. 1987 Feb; 19(1 Pt 3):1959-60.
    View in: PubMed
    Score: 0.004
  57. Intermediate normothermic hemoperfusion doubles safe cold preservation of rat kidneys. Transplant Proc. 1987 Feb; 19(1 Pt 2):1369-71.
    View in: PubMed
    Score: 0.004
  58. Potent immunosuppression overcomes retransplantation, presensitization, and historical positive crossmatch as transplant risk factors. Transplant Proc. 1987 Feb; 19(1 Pt 3):1915-6.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.